Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 311

1.

PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole.

Tipre DN, Zoghbi SS, Liow JS, Green MV, Seidel J, Ichise M, Innis RB, Pike VW.

J Nucl Med. 2006 Feb;47(2):345-53.

2.

Disulfiram inhibits defluorination of (18)F-FCWAY, reduces bone radioactivity, and enhances visualization of radioligand binding to serotonin 5-HT1A receptors in human brain.

Ryu YH, Liow JS, Zoghbi S, Fujita M, Collins J, Tipre D, Sangare J, Hong J, Pike VW, Innis RB.

J Nucl Med. 2007 Jul;48(7):1154-61. Epub 2007 Jun 15. Erratum in: J Nucl Med. 2008 Apr;49(4):596.

3.

18F-Mefway PET imaging of serotonin 1A receptors in humans: a comparison with 18F-FCWAY.

Choi JY, Lyoo CH, Kim JS, Kim KM, Kang JH, Choi SH, Kim JJ, Ryu YH.

PLoS One. 2015 Apr 1;10(4):e0121342. doi: 10.1371/journal.pone.0121342. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0127491.

4.

Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.

Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J.

J Nucl Med. 2006 Oct;47(10):1697-706.

5.

Effective microPET imaging of brain 5-HT(1A) receptors in rats with [(18) F]MeFWAY by suppression of radioligand defluorination.

Choi JY, Kim CH, Jeon TJ, Kim BS, Yi CH, Woo KS, Seo YB, Han SJ, Kim KM, Yi DI, Lee M, Kim DG, Kim JY, Lee KC, Choi TH, An G, Ryu YH.

Synapse. 2012 Dec;66(12):1015-23. doi: 10.1002/syn.21607. Epub 2012 Sep 29.

PMID:
22927318
6.

First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.

Hillmer AT, Wooten DW, Bajwa AK, Higgins AT, Lao PJ, Betthauser TJ, Barnhart TE, Rowley HA, Stone CK, Johnson SC, Mukherjee J, Christian BT.

J Nucl Med. 2014 Dec;55(12):1973-9. doi: 10.2967/jnumed.114.145151. Epub 2014 Nov 13.

7.

PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy.

Toczek MT, Carson RE, Lang L, Ma Y, Spanaki MV, Der MG, Fazilat S, Kopylev L, Herscovitch P, Eckelman WC, Theodore WH.

Neurology. 2003 Mar 11;60(5):749-56.

PMID:
12629228
8.

Determination of optimal acquisition time of [(18)F]FCWAY PET for imaging serotonin 1A receptors in the healthy male subjects.

Choi JY, Lee M, Jeon TJ, Choi SH, Choi YJ, Lee YK, Kim JJ, Ryu YH.

Appl Radiat Isot. 2014 Jul;89:141-5. doi: 10.1016/j.apradiso.2014.02.014. Epub 2014 Feb 22.

PMID:
24631746
9.

[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.

Pike VW, Halldin C, McCarron JA, Lundkvist C, Hirani E, Olsson H, Hume SP, Karlsson P, Osman S, Swahn CG, Hall H, Wikström H, Mensonidas M, Poole KG, Farde L.

Eur J Nucl Med. 1998 Apr;25(4):338-46.

PMID:
9553162
10.

Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹⁸F]mefway PET.

Saigal N, Bajwa AK, Faheem SS, Coleman RA, Pandey SK, Constantinescu CC, Fong V, Mukherjee J.

Synapse. 2013 Sep;67(9):596-608. doi: 10.1002/syn.21665. Epub 2013 Apr 18.

11.

N-(4-[(18)F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT(1A) receptors.

García G, Abet V, Alajarín R, Álvarez-Builla J, Delgado M, García-García L, Bascuñana-Almarcha P, Peña-Salcedo C, Kelly J, Pozo MA.

Eur J Med Chem. 2014 Oct 6;85:795-806. doi: 10.1016/j.ejmech.2014.07.096. Epub 2014 Jul 26.

PMID:
25171752
12.

5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction.

Giovacchini G, Toczek MT, Bonwetsch R, Bagic A, Lang L, Fraser C, Reeves-Tyer P, Herscovitch P, Eckelman WC, Carson RE, Theodore WH.

J Nucl Med. 2005 Jul;46(7):1128-35.

13.

Synthesis and in vivo biodistribution of F-18 labeled 3-cis-, 3-trans-, 4-cis-, and 4-trans-fluorocyclohexane derivatives of WAY 100635.

Lang L, Jagoda E, Ma Y, Sassaman MB, Eckelman WC.

Bioorg Med Chem. 2006 Jun 1;14(11):3737-48. Epub 2006 Feb 20.

PMID:
16488611
14.

18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy.

Liew CJ, Lim YM, Bonwetsch R, Shamim S, Sato S, Reeves-Tyer P, Herscovitch P, Dustin I, Bagic A, Giovacchini G, Theodore WH.

Epilepsia. 2009 Feb;50(2):234-9. doi: 10.1111/j.1528-1167.2008.01789.x. Epub 2008 Sep 17.

15.

Translational possibility of [18 F]Mefway to image serotonin 1A receptors in humans: Comparison with [18 F]FCWAY in rodents.

Choi JY, Kim BS, Kim CH, Kim DG, Han SJ, Lee K, Kim KM, An G, Choi TH, Yoo SD, Ryu YH.

Synapse. 2014 Jul 24. doi: 10.1002/syn.21771. [Epub ahead of print]

PMID:
25056144
16.

Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.

McCarron JA, Zoghbi SS, Shetty HU, Vermeulen ES, Wikström HV, Ichise M, Yasuno F, Halldin C, Innis RB, Pike VW.

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1670-82. Epub 2007 Jun 20.

PMID:
17579853
17.

Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT.

Jagoda EM, Lang L, Tokugawa J, Simmons A, Ma Y, Contoreggi C, Kiesewetter D, Eckelman WC.

Synapse. 2006 May;59(6):330-41.

PMID:
16440292
18.

Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats.

Defraiteur C, Lemaire C, Luxen A, Plenevaux A.

Nucl Med Biol. 2006 Jul;33(5):667-75. Epub 2006 Jun 12.

PMID:
16843842
19.

Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.

McCarron JA, Marchais-Oberwinkler S, Pike VW, Tarkiainen J, Halldin C, Sóvagó J, Gulyas B, Wikström HV, Farde L.

Mol Imaging Biol. 2005 May-Jun;7(3):209-19.

PMID:
15912425
20.

Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.

Osman S, Lundkvist C, Pike VW, Halldin C, McCarron JA, Swahn CG, Farde L, Ginovart N, Luthra SK, Gunn RN, Bench CJ, Sargent PA, Grasby PM.

Nucl Med Biol. 1998 Apr;25(3):215-23.

PMID:
9620626

Supplemental Content

Support Center